Parameter | Baseline | Treatment value at day 14 | Treatment differences (97.5% CI); p value | |||
SFC+TIO | TIO | SFC | Triple vs TIO | Triple vs SFC | ||
Mean (SD) TDI total score | 6.3 (1.73) | 2.3 (2.55) | 0.2 (3.09) | 1.7 (2.76) | 2.2 (0.8, 3.5); p<0.001 | 0.7 (−0.7, 2.1); p = 0.238 |
Improvement: TDI⩾1 (n (%)) | 21 (72) | 8 (27) | 14 (54) | |||
No change: TDI = 0 | 6 (21) | 15 (50) | 9 (35) | |||
Deterioration: TDI⩽−1 | 2 (7) | 7 (23) | 3 (12) | |||
Mean (SD) occasions of rescue medication use over 24 h | 3.2 (2.64) | 1.6 (1.60) | 2.6 (2.50) | 2.0 (2.23) | −1.0 (−1.5, −0.6); p<0.001 | −0.6 (−1.1, −0.1); p = 0.013 |
Treatment differences (SE); p value | ||||||
Mean (SD) morning PEF (treatment period) | 221.4 (84.8) | 265.8 (99.2) | 244.2 (101.2) | 249.1 (91.0) | 14.9 (−0.4, 30.3); p = 0.029 | 11.0 (−5.1, 27.1); p = 0.121 |
PEF, peak expiratory flow; SFC, salmeterol/fluticasone propionate combination; TDI, Transitional Dyspnoea Index; TIO, tiotropium.